Jete Biotech: As of March 23, a total of 18.7471 million yuan worth of shares have been repurchased.

Jeter Biology announced that it reviewed and approved a stock buyback plan on December 29, 2025, with a buyback fund of 15-30 million RMB, and the buyback period is until December 29, 2026. As of March 23, 2026, the company has repurchased 1.1175 million shares, accounting for 0.80% of the total share capital, and paid 18.7471 million RMB for the repurchase at a price range of 14.71-18.43 RMB per share. This buyback is in compliance with regulations, and the company will fulfill its disclosure obligations as required.